Back to search results
NCT07091396

Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery

Active, Not Recruiting
NAAges 18+InterventionalTreatment
Mayo Clinic
~55 participants
Updated 2026-08-19 on ClinicalTrials.gov
What's tested:Soterix® tDCS - Home treatmentCognitive-linguistic therapySoterix® tDCS - Lab treatment

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
For patients with post-stroke cognitive impairment--Stricker Learning Span and Symbols Test
Measured over Baseline, 3 weeks, 12 weeks, 15 weeks, 24 weeks
+1 more outcome measured

Conditions

Stroke
Neurodegeneration
Brain Tumor

Explore related trials

Brain NeoplasmNeurodegenerative ConditionsStroke

NCT07091396

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Mayo Clinic in Rochester

    Rochester, Minnesotano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Rene Utianski, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

At least 3 months after ischemic/hemorrhagic/anoxic stroke or 3 months after completion of cranial radiation or cranial surgery for treatment of primary or metastatic intracranial tumors or neurodegenerative conditions include, but are not limited to, primary progressive aphasia, corticobasal syndrome, progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease dementia.
Expected survival \>6 months
Functional impairment in the domains of language and/or cognition affecting quality of life determined by PI.
Have a legally authorized representative who is able to sign on their behalf in unable to consent for themselves (ex., individuals with aphasia).
Have a legally authorized representative who is able to sign on their behalf in unable to consent for themselves (ex., individuals with aphasia).

Exclusion

Pregnancy
Contraindication to tDCS, including metallic implanted objects.
Medical instability or inability to cooperate during the study as assessed by the treating physician to participate in the study.
Individuals with epilepsy

What this trial measures

  • For patients with post-stroke cognitive impairment--Stricker Learning Span and Symbols TestBaseline, 3 weeks, 12 weeks, 15 weeks, 24 weeks

    The Stricker Learning Span (SLS) is a computer-adaptive digital word list memory test specifically designed for remote assessment and self-administration on a web-based multi-device platform (Mayo Test Drive).

  • For patients with post-stroke language impairment--Mayo-developed web-based languageBaseline, 3 weeks, 12 weeks, 15 weeks, 24 weeks

    The exam includes a standard protocol including sentence and word repetition, standard reading passage, vowel prolongation, speech alternating motion rates , sequential motion rates, picture description, naming, and animal fluency